About: Idoxifene

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Idoxifene (INN, USAN, BAN) (former developmental code names CB-7432, SB-223030), also known as pyrrolidino-4-iodotamoxifen, is a nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group which was under development for the treatment of breast cancer and postmenopausal osteoporosis but was never marketed. It reached phase III clinical trials for postmenopausal osteoporosis and phase II clinical trials for breast cancer before development was discontinued in 1999 due to insufficient effectiveness in both cases.

Property Value
dbo:abstract
  • Idoxifene (INN, USAN, BAN) (former developmental code names CB-7432, SB-223030), also known as pyrrolidino-4-iodotamoxifen, is a nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group which was under development for the treatment of breast cancer and postmenopausal osteoporosis but was never marketed. It reached phase III clinical trials for postmenopausal osteoporosis and phase II clinical trials for breast cancer before development was discontinued in 1999 due to insufficient effectiveness in both cases. (en)
dbo:casNumber
  • 116057-75-1
dbo:chEMBL
  • 6318
dbo:fdaUniiCode
  • 456UXE9867
dbo:kegg
  • D04496
dbo:pubchem
  • 3034011
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 31358819 (xsd:integer)
dbo:wikiPageLength
  • 4207 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1017714090 (xsd:integer)
dbo:wikiPageWikiLink
dbp:c
  • 28 (xsd:integer)
dbp:casNumber
  • 116057 (xsd:integer)
dbp:chembl
  • 6318 (xsd:integer)
dbp:chemspiderid
  • 2298565 (xsd:integer)
dbp:eliminationHalfLife
  • 54000.0
  • 1987200.0
dbp:h
  • 30 (xsd:integer)
dbp:i
  • 1 (xsd:integer)
dbp:iupacName
  • 1 (xsd:integer)
dbp:kegg
  • D04496 (en)
dbp:n
  • 1 (xsd:integer)
dbp:o
  • 1 (xsd:integer)
dbp:pubchem
  • 3034011 (xsd:integer)
dbp:routesOfAdministration
dbp:smiles
  • CC/C/C4=CC=CC=C4 (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • JJKOTMDDZAJTGQ-DQSJHHFOSA-N (en)
dbp:synonyms
  • CB-7432, SB-223030; Pyrrolidino-4-iodotamoxifen; 4-Iodopyrrolidinotamoxifen (en)
dbp:unii
  • 456 (xsd:integer)
dbp:width
  • 250 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Idoxifene (INN, USAN, BAN) (former developmental code names CB-7432, SB-223030), also known as pyrrolidino-4-iodotamoxifen, is a nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group which was under development for the treatment of breast cancer and postmenopausal osteoporosis but was never marketed. It reached phase III clinical trials for postmenopausal osteoporosis and phase II clinical trials for breast cancer before development was discontinued in 1999 due to insufficient effectiveness in both cases. (en)
rdfs:label
  • Idoxifene (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License